Charles River Laboratories International (CRL) Net Margin (2009 - 2025)

Charles River Laboratories International's Net Margin history runs 16 years deep, the most recent figure standing at 27.82% for Q4 2025.

• In Q4 2025, Net Margin fell 630.0% year-over-year to 27.82%; the TTM figure through Dec 2025 stood at 3.59% (down 385.0% YoY), while the FY2025 annual figure was 3.59%, down 385.0% from the prior year.
• Net Margin for Q4 2025 stood at 27.82%, down from 5.42% in the prior quarter.
• The five-year high for Net Margin was 18.46% in Q4 2023, with the low at 27.82% in Q4 2025.
• The 5-year median for Net Margin is 8.96% (2023), against an average of 6.29%.
• The sharpest annual moves came in 2022 and 2024: Net Margin jumped 267 bps in 2022, then tumbled 3997 bps in 2024.
• Charles River Laboratories International's Net Margin stood at 15.45% in 2021, then climbed by 11 bps to 17.19% in 2022, then increased by 7 bps to 18.46% in 2023, then plunged by 217 bps to 21.52% in 2024, then retreated by 29 bps to 27.82% in 2025.
• Business Quant data shows CRL's Net Margin at 27.82% in Q4 2025, 5.42% in Q3 2025, and 5.07% in Q2 2025.